References
- Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013;10:e1001517.
- King MD, Whitney CG, Parekh F, Farley MM. Active Bacterial Core Surveillance Team/Emerging Infections Program Network. Recurrent invasive pneumococcal disease: a population-based assessment.Clin Infect Dis 2003; 37:1029–36.
- Einarsdóttir HM, Erlendsdóttir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect 2005;11:744–9.
- Mason EO, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J 2007;26:480–4.
- Behrman RE, Kliegman RM, Jenson HB. Nelsons textbook of paediatrics. 17th ed. Philadelphia: Saunders Elsevier; 2007 pp 867–9.
- McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, Kolano JA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002;185:1364–8.
- Hjuler T, Wohlfahrt J, Staum Kaltoft M, Koch A, Biggar RJ, Melbye M. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008;122: 26–32.
- Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003;299:2076–9.
- Ku CL, Picard C, Erdös M, Jeurissen A, Bustamante J, Puel A, et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2007;44:16–23.
- Lee W, Austrian R, Weiser JN. Recurrent pneumococcal bacteremia in normal children. Pediatr Infect Dis J 1994; 13:231–3.
- Orlizek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr 1997;130:284–8.
- Font B, Llimiñana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent bacteremia. Eur J Clin Microbiol Infect Dis 2001;20:636–8.
- Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcome. Arch Intern Med 2001;161:2141–4.
- Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Hjuler T, Kaltoft M, et al. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005.Vaccine 2008; 26:3765–7.
- EPINEWS. Pneumococcal vaccination of at-risk children; March 2007. Available at: http://www.ssi.dk/English/News/EPI-NEWS/~/media/Indhold/EN%20-%20engelsk/EPI-NEWS/2007/PDF/EPI-NEWS%20-%202007%20-%20No%2011.ashx (accessed 1 September 2013).
- EPINEWS. Pneumococcal vaccine in the Danish childhood vaccination programme; October 2007, Statens Serum Institut. Available at: http://www.ssi.dk/English/News/EPI-NEWS/~/media/Indhold/EN%20-%20engelsk/EPI-NEWS/2007/PDF/EPI-NEWS%20-%202007% 20-%20No%2037a.ashx (accessed 1 September 2013).
- EPINEWS. Pneumococcal infection and vaccination; October 1999. Available at: http://www.ssi.dk/Vaccination/Risikogrupper/media/Indhold/DK%20-%20dansk/Aktuelt/Nyhedsbreve/EPI-NYT/EPI-NYTArkiv/For%202000%20-%20ikke%20sogbar/EPI-NYT_44_1999.ashx (accessed 1 September 2013).
- Lambertsen L, Brendstrup M, Friis H, Christensen JJ. Molecular characterization of invasive penicillin non- susceptible Streptococcus pneumoniae from Denmark, 2001 to 2005.Scand J Infect Dis 2010;42:333–40.
- The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. EUCAST; 2013. Available at: http://www.eucast.org/clinical_breakpoints/ (accessed 13 September 2013).
- Harboe ZB, Valentiner-Branth P, Ingels H, Rasmussen JN, Andersen PH, Bjerre CC, et al. Danish Pneumococcal Surveillance Collaborating Group. Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.PLoS One 2013;8:e51460.
- Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, et al. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme. Vaccine 2012;30:3944–50.
- Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC 3rd, Sacerdote DM, et al. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998;17: 685–91.
- Patel SR, Bate J, Borrow R, Heath PT. Serotype-specific pneumococcal antibody concentrations in children treated for acute leukaemia. Arch Dis Child 2012;97:46–8.